Dog /
FDA CVM · 2025 release 22 reports on file

Spitz - Finnish - FDA Adverse Event Profile

Adverse-event records for Spitz - Finnish (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 4 3 2 1 0 2017 2018 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Spitz - Finnish drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

With 22 reports on file, Spitz - Finnish sits at #351 among dog breeds by volume; death-coded share is 13.6% (3 reports).

#351
most-reported dog breed
13.6%
death-coded report share
4
Vomiting - top reaction
10.4 yr
average age at report

Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.

Total Reports

22

FDA CVM filings

Deaths Reported

3

of 22 reports

Death Rate

13.6%

death-coded share

Avg Age at Report

10.4 yr

15.2 kg avg weight

Death-Coded Outcome Share

Spitz - Finnish death-coded reports 13.6%
Cross-breed median

13.6% of 22 spitz - finnish reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 15.2 kg (33.5 lbs)

Top Reported Reactions

Vomiting 4
Anorexia 4
Elevated lipase 4
Elevated alanine aminotransferase (ALT) 3
Diarrhoea 3

Most Referenced Drugs

Bedinvetmab 4
Trilostane 3
Milbemycin Oxime + Spinosad 2
Pyrantel Pamoate;Sarolaner 2
Sarolaner 2

Outcome Breakdown

Recovered/Normal
7 (31.8%)
Ongoing
6 (27.3%)
Outcome Unknown
6 (27.3%)
Euthanized
3 (13.6%)

Gender Distribution

Female 13 (59.1%)
Male 9 (40.9%)

Reports by Year

Year Reports Trend
2011 1
2013 1
2014 1
2015 1
2016 3
2017 1
2018 2
2020 2
2021 1
2022 2
2023 1
2024 4
2025 2

Spitz - Finnish Pet Health Insights

Spitz - Finnish accounts for 22 FDA adverse event reports, ranking #351 by volume among dog breeds, with 3 reports (13.6%) coded as a death outcome. Mean age at report: 10.4 years, average weight 15.2 kg (33.5 lbs).

Top reported signs: Vomiting (4), Anorexia (4), Elevated lipase (4). Most-referenced drug: Bedinvetmab (4 reports), followed by Trilostane (3) and Milbemycin Oxime + Spinosad (2).

Outcome coding on 22 status-recorded reports is dominated by Recovered/Normal (31.8%). Annual submissions ranged 2,011-2,025 across 13 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Spitz - Finnish?
There are 22 adverse event reports involving Spitz - Finnish in the FDA database, with 3 reports involving death (13.6% death rate). Spitz - Finnish ranks #351 by report volume.
What are the most common adverse reactions reported for Spitz - Finnish?
The most commonly reported adverse reactions for Spitz - Finnish are Vomiting (4 reports), Anorexia (4 reports), Elevated lipase (4 reports), Elevated alanine aminotransferase (ALT) (3 reports), Diarrhoea (3 reports).
What drugs are most frequently associated with Spitz - Finnish adverse events?
The drugs most frequently referenced in Spitz - Finnish adverse event reports are Bedinvetmab (4 reports), Trilostane (3 reports), Milbemycin Oxime + Spinosad (2 reports), Pyrantel Pamoate;Sarolaner (2 reports), Sarolaner (2 reports).
What is the average age of Spitz - Finnish in adverse event reports?
The average age of Spitz - Finnish at the time of adverse event reports is 10.4 years, with an average weight of 15.2 kg (33.5 lbs).
Does a high number of adverse event reports mean Spitz - Finnish is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Spitz - Finnish safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.